Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Switch to English

10642	Sociétés
226308	Mots-clés
154798	Articles
119785	Communiqués

Accueil
Sociétés
Jaguar Health, Inc.

COMMUNIQUÉ DE PRESSE

publié le 15/12/2025 à 15:00, il y a 6 mois 10 jours

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health announces submission of abstract detailing preliminary findings from clinical trial on a novel oral liquid formulation of crofelemer for SBS-IF patients, supporting the focus on reducing PS needs in intestinal failure patients

Crofelemer Jaguar Health Clinical Trial SBS-IF Intestinal Failure
BRÈVE

publiée le 10/12/2025 à 15:05, il y a 6 mois 15 jours

FDA Extends Conditional Approval for Jaguar Health's Canalevia-CA1

FDA Approval Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy In Dogs
BRÈVE

publiée le 10/12/2025 à 15:05, il y a 6 mois 15 jours

La FDA prolonge l'approbation conditionnelle du Canalevia-CA1 de Jaguar Health

Jaguar Health Canalevia-CA1 Approbation De La FDA Médecine Vétérinaire Chimiothérapie Chez Les Chiens
COMMUNIQUÉ DE PRESSE

publié le 10/12/2025 à 15:00, il y a 6 mois 15 jours

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) receives FDA renewal for Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea (CID) in dogs, with conditional approval extended until December 2026

Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea FDA Renewal
BRÈVE

publiée le 08/12/2025 à 22:20, il y a 6 mois 17 jours

Jaguar Health annonce l'approbation de propositions lors de l'assemblée générale des actionnaires

Crofelemer Jaguar Health Approbation De La FDA Assemblée Générale Des Actionnaires Maladie À Inclusions Microvillositaires
BRÈVE

publiée le 08/12/2025 à 22:20, il y a 6 mois 17 jours

Jaguar Health Announces Approval of Proposals at Stockholder Meeting

Crofelemer Microvillus Inclusion Disease FDA Approval Jaguar Health Stockholder Meeting
COMMUNIQUÉ DE PRESSE

publié le 08/12/2025 à 22:15, il y a 6 mois 17 jours

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
Jaguar CEO Lisa Conte to present updates on near-term catalysts at Emerging Growth Conference; Initial results show crofelemer may extend infants' lives with MVID; Jaguar completes FDA meeting on crofelemer trial for MVID treatment

Crofelemer Jaguar Health Lisa Conte Emerging Growth Conference MVID
BRÈVE

publiée le 02/12/2025 à 15:05, il y a 6 mois 23 jours

Jaguar Health sollicite l'approbation de l'EMA pour Canalevia dans le traitement de la diarrhée canine

Jaguar Health Agence Européenne Des Médicaments Diarrhée Du Chien Approbation De Canalevia Traitement Non Antibiotique
BRÈVE

publiée le 02/12/2025 à 15:05, il y a 6 mois 23 jours

Jaguar Health Seeks EMA Approval for Canalevia to Treat Dog Diarrhea

Jaguar Health European Medicines Agency Dog Diarrhea Canalevia Approval Non-antibiotic Treatment
COMMUNIQUÉ DE PRESSE

publié le 02/12/2025 à 15:00, il y a 6 mois 23 jours

Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Jaguar Health, Inc. requests advice from EMA on EU approval pathway for Canalevia® in treating general diarrhea in dogs. Novel non-antibiotic approach targets a significant market gap

Jaguar Health Dogs EMA Canalevia General Diarrhea

Les Echos

Publié le 26/06/2026 à 07:00, il y a 32 minutes

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Publié le 26/06/2026 à 07:00, il y a 32 minutes

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Publié le 25/06/2026 à 18:45, il y a 12 heures 47 minutes

Avis Financier Semestriel SFCMC au 30 avril 2026
Publié le 25/06/2026 à 18:30, il y a 13 heures 2 minutes

Avis financier semestriel SIEHM au 30 avril 2026
Publié le 25/06/2026 à 17:50, il y a 13 heures 42 minutes

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 26/06/2026 à 01:40, il y a 5 heures 52 minutes

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Publié le 25/06/2026 à 23:30, il y a 8 heures 2 minutes

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Publié le 25/06/2026 à 22:30, il y a 9 heures 2 minutes

Fountain Asset Corp. Provides Corporate Update
Publié le 25/06/2026 à 21:32, il y a 10 heures

BlackBerry Announces Election Results for the Company's Board of Directors
Publié le 25/06/2026 à 15:30, il y a 16 heures 2 minutes

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation

Voir tout ACCESSWIRE

EQS Group

Publié le 26/06/2026 à 04:20, il y a 3 heures 12 minutes

VARON Helps Travelers Breathe Easy This Summer With Portable Oxygen Concentrators Built for Mobility
Publié le 26/06/2026 à 02:05, il y a 5 heures 27 minutes

VARON Marks "Love Your Lungs Week" With a Call to Prioritize Summer Respiratory Health Across Europe
Publié le 25/06/2026 à 22:40, il y a 8 heures 52 minutes

DeFi Technologies Inc. Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Publié le 25/06/2026 à 19:00, il y a 12 heures 31 minutes

EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Publié le 25/06/2026 à 18:59, il y a 12 heures 33 minutes

OHB Digital Connect completes upgrade of military ground stations